CAL
VIR icon

Capital Analysts LLC’s Vir Biotechnology VIR Stock Holding History

Capital Analysts LLC’s Portfolio VIR Stock Details VIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-320
Closed -$3K – 1367
2024
Q2 		$3K Hold
320
– – ﹤0.01% 1093
2024
Q1 		$3K Hold
320
– – ﹤0.01% 1039
2023
Q4 		$3K Hold
320
– – ﹤0.01% 1006
2023
Q3 		$3K Sell
320
-15
-4% -$214 ﹤0.01% 1037
2023
Q2 		$8K Hold
335
– – ﹤0.01% 846
2023
Q1 		$8K Buy
335
+90
+37% +$2.3K ﹤0.01% 827
2022
Q4 		$6K Hold
245
– – ﹤0.01% 903
2022
Q3 		$5K Buy
245
+50
+26% +$1.27K ﹤0.01% 896
2022
Q2 		$5K Buy
+195
New +$4.55K ﹤0.01% 871

Other funds holding VIR

SIAU
SB Investment Advisers (UK) London, United Kingdom $7.73B AUM 2.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
GF
Gates Foundation Seattle, Washington $43.5M AUM 14.19% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return